2024-12-01 2025-11-30 false No description of principal activity Capium Accounts Production 1.1 15256173 2024-12-01 2025-11-30 15256173 bus:AbridgedAccounts 2024-12-01 2025-11-30 15256173 bus:Micro-entities 2024-12-01 2025-11-30 15256173 bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 15256173 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 15256173 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 15256173 2024-12-01 2025-11-30 15256173 2025-11-30 15256173 bus:RegisteredOffice 2024-12-01 2025-11-30 15256173 core:WithinOneYear 2025-11-30 15256173 core:AfterOneYear 2025-11-30 15256173 1 2024-12-01 2025-11-30 15256173 bus:Director1 2024-12-01 2025-11-30 15256173 bus:Director1 2025-11-30 15256173 bus:Director1 2023-11-02 2024-11-30 15256173 2023-11-02 15256173 bus:LeadAgentIfApplicable 2024-12-01 2025-11-30 15256173 2023-11-02 2024-11-30 15256173 2024-11-30 15256173 core:WithinOneYear 2024-11-30 15256173 core:AfterOneYear 2024-11-30 15256173 bus:EntityAccountantsOrAuditors 2023-11-02 2024-11-30 15256173 core:ComputerEquipment 2024-12-01 2025-11-30 15256173 core:ComputerEquipment 2025-11-30 15256173 core:ComputerEquipment 2024-11-30 15256173 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-11-30 15256173 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-11-30 15256173 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 15256173 core:CostValuation core:Non-currentFinancialInstruments 2024-11-30 15256173 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 15256173 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 15256173 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 15256173 core:Non-currentFinancialInstruments 2025-11-30 15256173 core:Non-currentFinancialInstruments 2024-11-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 15256173
England and Wales
AMM CLINICAL SERVICES LTD
Abridged Accounts
Period of accounts Start date: 01 December 2024 End date: 30 November 2025

AMM CLINICAL SERVICES LTD Contents Page For the year ended 30 November 2025
Statement of financial position | 1

AMM CLINICAL SERVICES LTD Statement of Financial Position As at 30 November 2025
|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Fixed assets |  |  | 0 |  |  | 190
Current assets |  | 721 |  |  | 2,271 |
Creditors: amount falling due within one year |  | (1,639) |  |  | (1,488) |
Net current assets |  |  | (918) |  |  | 783
Total assets less current liabilities |  |  | (918) |  |  | 973
Net assets |  |  | (918) |  |  | 973
Capital and reserves |  |  | (918) |  |  | 973
NOTES TO THE ACCOUNTS General Information AMM CLINICAL SERVICES LTD is a private company, limited by shares, registered in England and Wales, registration number 15256173, registration address 5 CANON COURT, INSTITUTE STREET BOLTON, BL1 1PZ. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention. The financial statements are prepared in sterling which is the functional currency of the company.
2. | Average number of employees Average number of employees during the year was 1 (2024 : 1).
For the year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's Responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts. The financial statements were approved by the director on 16 April 2026 and were signed by:
-------------------------------- Antonio Meca Martinez Director
1